Roche Holding AG
SIX:ROG

Watchlist Manager
Roche Holding AG Logo
Roche Holding AG
SIX:ROG
Watchlist
Price: 307.4 CHF -0.61% Market Closed
Market Cap: 248.8B CHF

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Roche Holding AG

Revenue
61.6B CHF
Cost of Revenue
-16.1B CHF
Gross Profit
45.5B CHF
Operating Expenses
-24.7B CHF
Operating Income
20.8B CHF
Other Expenses
-11.4B CHF
Net Income
9.4B CHF

Margins Comparison
Roche Holding AG Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CH
Roche Holding AG
SIX:ROG
244.7B CHF
74%
34%
15%
US
Eli Lilly and Co
NYSE:LLY
1T USD
83%
44%
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
56%
3%
-4%
US
Johnson & Johnson
NYSE:JNJ
497.9B USD
68%
27%
27%
UK
AstraZeneca PLC
LSE:AZN
216.7B GBP
82%
24%
16%
US
Merck & Co Inc
NYSE:MRK
260.7B USD
79%
38%
30%
CH
Novartis AG
SIX:NOVN
200.5B CHF
76%
33%
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
82%
42%
33%
IE
Endo International PLC
LSE:0Y5F
202B USD
68%
11%
-126%
US
Pfizer Inc
NYSE:PFE
146.4B USD
75%
29%
16%
FR
Sanofi SA
PAR:SAN
104.4B EUR
72%
24%
21%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Roche Holding AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Roche Holding AG
SIX:ROG
244.7B CHF
33%
10%
31%
18%
US
Eli Lilly and Co
NYSE:LLY
1T USD
97%
19%
42%
25%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
-2%
2%
2%
US
Johnson & Johnson
NYSE:JNJ
497.9B USD
33%
13%
18%
13%
UK
AstraZeneca PLC
LSE:AZN
216.7B GBP
22%
9%
18%
15%
US
Merck & Co Inc
NYSE:MRK
260.7B USD
40%
15%
26%
21%
CH
Novartis AG
SIX:NOVN
200.5B CHF
33%
14%
25%
18%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
71%
23%
57%
28%
IE
Endo International PLC
LSE:0Y5F
202B USD
70%
-51%
5%
6%
US
Pfizer Inc
NYSE:PFE
146.4B USD
11%
5%
11%
10%
FR
Sanofi SA
PAR:SAN
104.4B EUR
19%
11%
16%
12%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less